FI20012462L - Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia - Google Patents

Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia Download PDF

Info

Publication number: FI20012462L
Authority: FI; Finland
Prior art keywords: methods; pharmaceutical formulations; intranasal morphine; morphine; intranasal
Prior art date: 1999-06-16

Application number

FI20012462A

Other languages

English (en)

Swedish (sv)

Other versions

FI20012462A7 (fi

Inventor

Raja G Achari

Jorge C Demeireles

Vincent D Romeo

Charanjit R Behl

Ramneik Dua

Anthony P Sileno

Original Assignee

Nastech Pharm Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-16

Filing date

2000-05-23

Publication date

2002-01-16

2000-05-23 Application filed by Nastech Pharm Co filed Critical Nastech Pharm Co

2002-01-16 Publication of FI20012462L publication Critical patent/FI20012462L/fi

2002-01-16 Publication of FI20012462A7 publication Critical patent/FI20012462A7/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

FI20012462A 1999-06-16 2000-05-23 Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia FI20012462A7 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33453799A	1999-06-16	1999-06-16
PCT/US2000/014157 WO2000076506A1 (en)	1999-06-16	2000-05-23	Pharmaceutical formulations and methods comprising intranasal morphine

Publications (2)

Publication Number	Publication Date
FI20012462L true FI20012462L (fi)	2002-01-16
FI20012462A7 FI20012462A7 (fi)	2002-01-16

Family

ID=23307687

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI20012462A FI20012462A7 (fi)	1999-06-16	2000-05-23	Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia

Country Status (30)

Country	Link
US (1)	US6677346B1 (fi)
EP (2)	EP1419774A1 (fi)
JP (1)	JP2003501467A (fi)
KR (1)	KR20020016831A (fi)
AU (1)	AU774175B2 (fi)
BG (1)	BG106221A (fi)
BR (1)	BR0012082A (fi)
CA (1)	CA2374877C (fi)
CZ (1)	CZ20014399A3 (fi)
DE (1)	DE10084709T1 (fi)
DK (1)	DK200101859A (fi)
EE (1)	EE200100677A (fi)
ES (1)	ES2197792B1 (fi)
FI (1)	FI20012462A7 (fi)
GB (1)	GB2367005A (fi)
HR (1)	HRP20010926A2 (fi)
HU (1)	HUP0201856A3 (fi)
IS (1)	IS6202A (fi)
LT (1)	LT4976B (fi)
LU (1)	LU90859B1 (fi)
LV (1)	LV12859B (fi)
MX (1)	MXPA01012879A (fi)
NO (1)	NO20015931L (fi)
NZ (1)	NZ515783A (fi)
PL (1)	PL352556A1 (fi)
SE (1)	SE0104203D0 (fi)
SI (1)	SI20850A (fi)
SK (1)	SK18172001A3 (fi)
TR (1)	TR200103613T2 (fi)
WO (1)	WO2000076506A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9924797D0 (en)	1999-10-20	1999-12-22	West Pharm Serv Drug Res Ltd	Compound
US20040115133A1 (en) *	2000-05-10	2004-06-17	Wermeling Daniel P.	Intranasal opioid compositions
US20060083691A1 (en) *	2000-05-10	2006-04-20	Wermeling Daniel P	Intranasal opioid compositions, delivery devices and methods of using same
AU2001291159A1 (en) *	2000-09-20	2002-04-02	Shahinian Jr., Lee	Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
WO2003002071A2 (en) *	2001-06-29	2003-01-09	Lewandowski Leon J	Individualized addiction cessation therapy
GB0210264D0 (en) *	2002-05-03	2002-06-12	Arakis Ltd	The treatment of pain and migraine headache
US20040102476A1 (en) *	2002-11-25	2004-05-27	Chan Tai Wah	High concentration formulations of opioids and opioid derivatives
US20050175679A1 (en) *	2004-02-10	2005-08-11	Michael Moshman	Controlled release formulations
US9895444B2 (en)	2004-08-25	2018-02-20	Aegis Therapeutics, Llc	Compositions for drug administration
US20140162965A1 (en)	2004-08-25	2014-06-12	Aegis Therapeutics, Inc.	Compositions for oral drug administration
LT2377557T (lt)	2004-11-24	2017-02-10	Meda Pharmaceuticals Inc.	Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai
US9415034B2 (en) *	2005-01-05	2016-08-16	National Defense Medical Center	Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
ES2277743B2 (es) *	2005-06-02	2008-12-16	Universidade De Santiago De Compostela	Nanoparticulas que comprenden quitosano y ciclodextrina.
ATE458491T1 (de)	2005-08-26	2010-03-15	Univ Leland Stanford Junior	Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin
US20070212307A1 (en) *	2006-02-10	2007-09-13	Daniel Wermeling	Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
US8226949B2 (en)	2006-06-23	2012-07-24	Aegis Therapeutics Llc	Stabilizing alkylglycoside compositions and methods thereof
JP5315252B2 (ja) *	2006-12-22	2013-10-16	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ	眼科用薬物の輸送に有用なゲル
GB2477545B (en) *	2010-02-05	2011-12-21	Special Products Ltd	A liquid morphine composition for buccal administration
CA2835940C (en)	2011-05-13	2020-08-04	Euro-Celtique S.A.	Intranasal pharmaceutical dosage forms comprising naloxone
US20150231130A1 (en)	2012-07-26	2015-08-20	Wockhardt Limited	Pharmaceutical composition comprising diamorphine for intranasal administration
WO2015095389A1 (en) *	2013-12-18	2015-06-25	Aegis Therapeutics, Llc	Compositions for drug administration
US11135155B2 (en)	2014-07-08	2021-10-05	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray
PT3242676T (pt)	2015-01-07	2023-12-06	TONIX Pharmaceuticals Holding Corp	Formulações de ocitocina que contém magnésio e métodos de uso
CN115814055A (zh)	2016-04-12	2023-03-21	三叉神经股份公司	含镁催产素制剂和应用方法
WO2018075979A1 (en) *	2016-10-21	2018-04-26	Somniferum Labs LLC	Compositions, methods and kits for the safe inhaled delivery of targeted opioids for the treatment of pain and addiction
WO2019076997A1 (en) *	2017-10-20	2019-04-25	Chiesi Farmaceutici S.P.A.	PHARMACEUTICAL FORMULATIONS COMPRISING AN OPIOID RECEPTOR AGONIST AS ACTIVE SUBSTANCES, METHODS OF MAKING THEM AND THERAPEUTIC USES THEREOF
WO2019157099A1 (en)	2018-02-06	2019-08-15	Aegis Therapeutics, Llc	Intranasal epinephrine formulations and methods for the treatment of disease
CN115804754A (zh) *	2022-12-16	2023-03-17	广州新济药业科技有限公司	吗啡鼻喷剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4464378A (en) *	1981-04-28	1984-08-07	University Of Kentucky Research Foundation	Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4464376A (en)	1982-07-22	1984-08-07	Richardson-Vicks, Inc.	Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB8514665D0 (en) *	1985-06-11	1985-07-10	Eroceltique Sa	Oral pharmaceutical composition
US5202128A (en)	1989-01-06	1993-04-13	F. H. Faulding & Co. Limited	Sustained release pharmaceutical composition
GB9202464D0 (en) *	1992-02-05	1992-03-18	Danbiosyst Uk	Composition for nasal administration
AU6428894A (en) *	1993-03-26	1994-10-24	Franciscus W.H.M. Merkus	Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine
GB9426102D0 (en)	1994-12-23	1995-02-22	Merck Sharp & Dohme	Pharmacuetical compositions
EP1006969A1 (en) *	1996-09-27	2000-06-14	Nastech Pharmaceutical Co.	Intranasal formulations for promoting sleep and method of using the same

2000
- 2000-05-23 DE DE10084709T patent/DE10084709T1/de not_active Ceased
- 2000-05-23 EP EP04001252A patent/EP1419774A1/en not_active Withdrawn
- 2000-05-23 ES ES200150086A patent/ES2197792B1/es not_active Expired - Lifetime
- 2000-05-23 FI FI20012462A patent/FI20012462A7/fi not_active IP Right Cessation
- 2000-05-23 TR TR2001/03613T patent/TR200103613T2/xx unknown
- 2000-05-23 SI SI200020030A patent/SI20850A/sl not_active IP Right Cessation
- 2000-05-23 GB GB0128383A patent/GB2367005A/en not_active Withdrawn
- 2000-05-23 NZ NZ515783A patent/NZ515783A/en unknown
- 2000-05-23 HU HU0201856A patent/HUP0201856A3/hu unknown
- 2000-05-23 CA CA002374877A patent/CA2374877C/en not_active Expired - Fee Related
- 2000-05-23 PL PL00352556A patent/PL352556A1/xx not_active Application Discontinuation
- 2000-05-23 SK SK1817-2001A patent/SK18172001A3/sk unknown
- 2000-05-23 HR HR20010926A patent/HRP20010926A2/hr not_active Application Discontinuation
- 2000-05-23 AU AU51561/00A patent/AU774175B2/en not_active Ceased
- 2000-05-23 JP JP2001502839A patent/JP2003501467A/ja active Pending
- 2000-05-23 WO PCT/US2000/014157 patent/WO2000076506A1/en not_active Ceased
- 2000-05-23 CZ CZ20014399A patent/CZ20014399A3/cs unknown
- 2000-05-23 EP EP00936212A patent/EP1183027A4/en not_active Withdrawn
- 2000-05-23 EE EEP200100677A patent/EE200100677A/xx unknown
- 2000-05-23 KR KR1020017016009A patent/KR20020016831A/ko not_active Ceased
- 2000-05-23 BR BR0012082-0A patent/BR0012082A/pt not_active IP Right Cessation
- 2000-05-23 MX MXPA01012879A patent/MXPA01012879A/es unknown
- 2000-06-15 US US09/594,916 patent/US6677346B1/en not_active Expired - Fee Related
2001
- 2001-12-04 NO NO20015931A patent/NO20015931L/no not_active Application Discontinuation
- 2001-12-12 DK DK200101859A patent/DK200101859A/da not_active Application Discontinuation
- 2001-12-13 LT LT2001119A patent/LT4976B/lt not_active IP Right Cessation
- 2001-12-13 LU LU90859A patent/LU90859B1/en active
- 2001-12-14 IS IS6202A patent/IS6202A/is unknown
- 2001-12-14 SE SE0104203A patent/SE0104203D0/xx not_active Application Discontinuation
- 2001-12-14 BG BG106221A patent/BG106221A/xx unknown
2002
- 2002-01-18 LV LVP-01-169A patent/LV12859B/en unknown

Also Published As

Publication number	Publication date
BG106221A (bg)	2002-08-30
KR20020016831A (ko)	2002-03-06
NZ515783A (en)	2004-05-28
HUP0201856A3 (en)	2004-12-28
EP1419774A1 (en)	2004-05-19
PL352556A1 (en)	2003-08-25
EP1183027A1 (en)	2002-03-06
FI20012462A7 (fi)	2002-01-16
SK18172001A3 (sk)	2002-07-02
CA2374877C (en)	2004-04-13
JP2003501467A (ja)	2003-01-14
LT4976B (lt)	2002-12-30
GB2367005A (en)	2002-03-27
IS6202A (is)	2001-12-14
ES2197792B1 (es)	2005-05-01
AU774175B2 (en)	2004-06-17
CA2374877A1 (en)	2000-12-21
ES2197792A1 (es)	2004-01-01
WO2000076506A1 (en)	2000-12-21
LU90859B1 (en)	2002-01-24
TR200103613T2 (tr)	2004-08-23
GB0128383D0 (en)	2002-01-16
NO20015931L (no)	2002-02-08
US6677346B1 (en)	2004-01-13
DE10084709T1 (de)	2002-09-26
HUP0201856A1 (en)	2002-09-28
MXPA01012879A (es)	2003-06-24
EP1183027A4 (en)	2003-02-05
NO20015931D0 (no)	2001-12-04
HRP20010926A2 (en)	2003-04-30
LV12859B (en)	2002-12-20
BR0012082A (pt)	2002-05-07
EE200100677A (et)	2003-02-17
AU5156100A (en)	2001-01-02
DK200101859A (da)	2001-12-12
SE0104203L (sv)	2001-12-14
CZ20014399A3 (cs)	2002-06-12
SI20850A (sl)	2002-10-31
LT2001119A (en)	2002-07-25
SE0104203D0 (sv)	2001-12-14

Publication	Publication Date	Title
FI20012462L (fi)	2002-01-16	Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia
EE200100714A (et)	2003-04-15	Farmatseutiliste ravimvormide pihustamissüsteemidja -meetodid
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
NO992339D0 (no)	1999-05-14	Farmas°ytiske formuleringer
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
NO20014323L (no)	2001-11-14	Vaksine
FI19992360L (fi)	2001-05-02	Tuote ja menetelmä sen valmistamiseksi
IS6040A (is)	2001-08-07	Valdekoxib efnablöndur
DK1073417T3 (da)	2003-03-24	Farmaceutisk aerosolformulering
DE60024731D1 (de)	2006-01-19	Ritzgerät
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
DE60002650D1 (de)	2003-06-18	Öladjuvierter Impfstoff
NO20020763L (no)	2002-04-16	Vaksine
NO20015670L (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
EP1299337A4 (en)	2004-10-13	HYDROXYPHENSTATIN AND ITS PROMEDICATIONS
NO20022606L (no)	2002-07-11	Farmasöytiske kombinasjoner
DE60028486D1 (de)	2006-07-20	Videocoder und -decoder
ID30032A (id)	2001-11-01	Formulasi farmasi
PT1178981E (pt)	2003-11-28	3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DK199900435U3 (da)	2000-02-11	Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
DE60117096D1 (de)	2006-04-20	Dihydroindol- und tetrahydrochinolinderivate
IS6163A (is)	2001-11-16	Lyfjakomplex
NO20004816D0 (no)	2000-09-26	Ny farmasøytisk formulering
FR2802775B1 (fr)	2005-06-03	Preparations glacees et aerees

Legal Events

Date	Code	Title	Description
2004-11-30	MA	Patent expired